MYCN、神经母细胞瘤与黏着斑激酶（FAK）。
MYCN, neuroblastoma and focal adhesion kinase (FAK).
作者信息
Beierle Elizabeth A
机构信息
University of Alabama, Birmingham, Birmingham, AL 35233, USA.
出版信息
Front Biosci (Elite Ed). 2011 Jan 1;3(2):421-33. doi: 10.2741/e257.
Abstract
Neuroblastoma is the most common extracranial solid tumor of childhood. This tumor is characterized by poor survival, especially when it features amplification of the MYCN oncogene. The ability for human cancers to propagate is marked by their ability to invade and metastasize to distant sites. Focal adhesion kinase (FAK) is a key tyrosine kinase involved in the survival and metastasis of a number of human tumor types. We have shown that FAK is present in human neuroblastoma and that its expression in neuroblastoma is related to the MYCN oncogene. We have also demonstrated that inhibition of FAK in neuroblastoma leads to decreased tumor cell survival. The current review addresses the relationship between the MYCN oncogene, focal adhesion kinase and neuroblastoma.
摘要
神经母细胞瘤是儿童最常见的颅外实体瘤。这种肿瘤的特点是生存率低，尤其是当它具有MYCN癌基因扩增特征时。人类癌症的增殖能力以其侵袭和转移到远处部位的能力为标志。粘着斑激酶（FAK）是一种关键的酪氨酸激酶，参与多种人类肿瘤类型的生存和转移。我们已经表明FAK存在于人类神经母细胞瘤中，并且其在神经母细胞瘤中的表达与MYCN癌基因有关。我们还证明，抑制神经母细胞瘤中的FAK会导致肿瘤细胞存活率降低。本综述探讨了MYCN癌基因、粘着斑激酶与神经母细胞瘤之间的关系。
相似文献
1
MYCN, neuroblastoma and focal adhesion kinase (FAK).MYCN、神经母细胞瘤与黏着斑激酶（FAK）。
Front Biosci (Elite Ed). 2011 Jan 1;3(2):421-33. doi: 10.2741/e257.
2
Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.抑制黏着斑激酶可减少人神经母细胞瘤的肿瘤生长。
Cell Cycle. 2010 Mar 1;9(5):1005-15. doi: 10.4161/cc.9.5.10936. Epub 2010 Mar 14.
3
The interaction between FAK, MYCN, p53 and Mdm2 in neuroblastoma.神经母细胞瘤中 FAK、MYCN、p53 和 Mdm2 的相互作用。
Anticancer Agents Med Chem. 2014 Jan;14(1):46-51. doi: 10.2174/18715206113136660331.
4
Targeting the MYCN effector, FAK, in neuroblastoma.靶向神经母细胞瘤中的MYCN效应因子粘着斑激酶（FAK）。
Cell Cycle. 2010 Mar 15;9(6):1026.
5
Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines.抑制黏着斑激酶和 src 可增加人神经母细胞瘤细胞系的脱离和凋亡。
Mol Carcinog. 2010 Mar;49(3):224-34. doi: 10.1002/mc.20592.
6
Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.神经母细胞瘤中焦点 DNA 拷贝数变化的靶基因是 MYCN 调控基因。
PLoS One. 2013;8(1):e52321. doi: 10.1371/journal.pone.0052321. Epub 2013 Jan 4.
7
Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells.鉴定MYCN基因网络并使其药理失活作为神经母细胞瘤细胞的一种治疗策略。
J Biol Chem. 2015 Jan 23;290(4):2198-212. doi: 10.1074/jbc.M114.624056. Epub 2014 Dec 4.
8
The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma.激酶ALK刺激激酶ERK5，以促进神经母细胞瘤中癌基因MYCN的表达。
Sci Signal. 2014 Oct 28;7(349):ra102. doi: 10.1126/scisignal.2005470.
9
ALK pERKs up MYCN in neuroblastoma.间变性淋巴瘤激酶（ALK）激活的细胞外信号调节激酶（pERKs）在神经母细胞瘤中上调MYCN基因。
Sci Signal. 2014 Oct 28;7(349):pe27. doi: 10.1126/scisignal.2005940.
10
Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesis.舒尼替尼通过降解MYCN和抑制血管生成来抑制神经母细胞瘤的生长。
PLoS One. 2014 Apr 23;9(4):e95628. doi: 10.1371/journal.pone.0095628. eCollection 2014.
引用本文的文献
1
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.EZH2 抑制可降低神经母细胞瘤的增殖和体内肿瘤生长。
PLoS One. 2021 Mar 9;16(3):e0246244. doi: 10.1371/journal.pone.0246244. eCollection 2021.
2
Copy Number Analysis Reveal Genetic Risks of Penile Cancer.拷贝数分析揭示阴茎癌的遗传风险。
Front Oncol. 2020 Dec 14;10:596261. doi: 10.3389/fonc.2020.596261. eCollection 2020.
3
MycN promotes TRPM7 expression and cell migration in neuroblastoma through a process that involves polyamines.MycN 通过多胺途径促进神经母细胞瘤中 TRPM7 的表达和细胞迁移。
FEBS Open Bio. 2014 Oct 30;4:966-75. doi: 10.1016/j.fob.2014.10.012. eCollection 2014.
本文引用的文献
1
Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells.Myc 因子直接和协调调控 ATP 结合盒转运蛋白基因，产生特定的转录特征，显著影响癌细胞的化疗耐药表型。
J Biol Chem. 2010 Jun 18;285(25):19532-43. doi: 10.1074/jbc.M109.078584. Epub 2010 Mar 16.
2
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.miR-9，一种 MYC/MYCN 激活的 microRNA，调节 E-钙黏蛋白和癌症转移。
Nat Cell Biol. 2010 Mar;12(3):247-56. doi: 10.1038/ncb2024. Epub 2010 Feb 21.
3
Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.抑制黏着斑激酶可减少人神经母细胞瘤的肿瘤生长。
Cell Cycle. 2010 Mar 1;9(5):1005-15. doi: 10.4161/cc.9.5.10936. Epub 2010 Mar 14.
4
Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation.在神经母细胞瘤中进行的全球 MYCN 转录因子结合分析揭示了与不同 E 盒基序和 DNA 超甲基化区域的关联。
PLoS One. 2009 Dec 4;4(12):e8154. doi: 10.1371/journal.pone.0008154.
5
Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines.抑制黏着斑激酶和 src 可增加人神经母细胞瘤细胞系的脱离和凋亡。
Mol Carcinog. 2010 Mar;49(3):224-34. doi: 10.1002/mc.20592.
6
A novel strategy to inhibit FAK and IGF-1R decreases growth of pancreatic cancer xenografts.一种新的抑制 FAK 和 IGF-1R 的策略可抑制胰腺癌异种移植物的生长。
Mol Carcinog. 2010 Feb;49(2):200-9. doi: 10.1002/mc.20590.
7
MycN is a transcriptional regulator of livin in neuroblastoma.MycN是神经母细胞瘤中livin的转录调节因子。
Oncol Rep. 2009 Oct;22(4):831-5. doi: 10.3892/or_00000506.
8
A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth.一种靶向粘着斑激酶Y397位点的小分子抑制剂——1,2,4,5-苯四胺四盐酸盐可抑制肿瘤生长。
J Med Chem. 2008 Dec 11;51(23):7405-16. doi: 10.1021/jm800483v.
9
MYCN downregulates integrin alpha1 to promote invasion of human neuroblastoma cells.MYCN下调整合素α1以促进人神经母细胞瘤细胞的侵袭。
Int J Oncol. 2008 Oct;33(4):815-21.
10
Histological profile of tumours from MYCN transgenic mice.MYCN转基因小鼠肿瘤的组织学特征
J Clin Pathol. 2008 Oct;61(10):1098-103. doi: 10.1136/jcp.2007.054627. Epub 2008 Aug 4.
Zotero 插件